国际药物开发与研究杂志

  • 国际标准期刊号: 0975-9344
  • 期刊 h 指数: 44
  • 期刊引用分数: 59.93
  • 期刊影响因子: 48.80
索引于
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 研究期刊索引目录 (DRJI)
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 欧洲酒吧
  • 谷歌学术
  • 夏尔巴罗密欧
  • 秘密搜索引擎实验室
  • 研究之门
分享此页面

抽象的

Method Validation and Estimation of Anagrelide Hydrochloride in Pharmaceutical Dosage by RP-HPLC Method

Nataraj KS, Prasanna Lakshmi B and Sravanthi I

A simple, fast and reproducible reverse phase liquid chromatography (RP-HPLC) method was developed for the determination of Anagrelide Hydrochloride in bulk drug and pharmaceutical dosage form. The method was developed using Inertsil ODS-3V C18 (150 × 4.6 mm, 5 μm) column, mobile phase 0.1% triethylamine in Milli-Q-water (pH 3.0 adjusted with orthophosphoric acid) and acetonitrile in the ratio of 70:30% v/v with isocratic elution at a flow rate of 1 mL/min. System Suitability test were performed for the assurance of quality performance of method. The drug was subjected to accelerated degradation for photolytic, hydrolytic, thermal, oxidative conditions. The retention time of Anagrelide Hydrochloride was found to be 6.985 min. The method was validated for accuracy, precision, specificity, linearity, limit of detection, limit of quantitation and robustness as per ICH guidelines. All the parameters were within limits. The mean recovery was 99.9%. Limit of detection was found to be 2.99 μg/ml and limit of quantitation was found to be 9.96 μg/ml. The proposed method gave good resolution of Anagrelide Hydrochloride and its degradation products. The developed method can be used for the routine quality control analysis.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证